Soluble VEGF receptors
The three human VEGF receptors 1-3 mediate biological signals important for new blood vessel formation and lymphangiogenesis. Soluble VEGF receptors contain all the information necessary for high affinity ligand binding and have been used as experimental tools and regulators in several angiogenic in...
Gespeichert in:
| Veröffentlicht in: | Angiogenesis (London) 1999-03, Vol.3 (1), p.33-39 |
|---|---|
| Hauptverfasser: | , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 39 |
|---|---|
| container_issue | 1 |
| container_start_page | 33 |
| container_title | Angiogenesis (London) |
| container_volume | 3 |
| creator | Hornig, C Weich, H A |
| description | The three human VEGF receptors 1-3 mediate biological signals important for new blood vessel formation and lymphangiogenesis. Soluble VEGF receptors contain all the information necessary for high affinity ligand binding and have been used as experimental tools and regulators in several angiogenic in vitro and in vivo models. Recombinant receptor molecules can be used for specific inhibition of VEGF mediated signal transduction and for blocking tumor angiogenesis by limiting the amount of VEGF secreted from tumor cells or stroma cells. A naturally occurring soluble VEGFR-1 has been discovered in the supernatant from endothelial cells and at present appears to be the key regulator for the availability of VEGF secreted from different cells and tissues. The exact physiological role has not yet been demonstrated. |
| doi_str_mv | 10.1023/A:1009033017809 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_69535552</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>386043761</sourcerecordid><originalsourceid>FETCH-LOGICAL-p1092-66d2634c66a6632096968e38e9374505c0797f266940fdfd286dbc92bac27f0c3</originalsourceid><addsrcrecordid>eNp10M1Lw0AQBfBFFBurV71JUfAWndmP2UxvpbRVKHjw4xqSzQZakiZmm4P_vRHrRfA0lx_vPUaIK4R7BKkeZlMEYFAK0CbARyJCY1VsJfCxiICJY2ILI3EWwhYGSok-FSPUBq3WMhKXL03V55WfvC9Wy0nnnW_3TRfOxUmZVcFfHO5YvC0Xr_PHeP28eprP1nGLwDImKiQp7YgyIiW_-yjxKvGsrDZgHFi2pSRiDWVRFjKhIncs88xJW4JTY3H3k9t2zUfvwz6tN8H5qsp2vulDSmyUMUYO8PYP3DZ9txu2pXJAyAioBnXzr0LUFtiaAV0fUJ_XvkjbblNn3Wf6-xT1BfJ5XhU</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>211470975</pqid></control><display><type>article</type><title>Soluble VEGF receptors</title><source>SpringerLink Journals</source><creator>Hornig, C ; Weich, H A</creator><creatorcontrib>Hornig, C ; Weich, H A</creatorcontrib><description>The three human VEGF receptors 1-3 mediate biological signals important for new blood vessel formation and lymphangiogenesis. Soluble VEGF receptors contain all the information necessary for high affinity ligand binding and have been used as experimental tools and regulators in several angiogenic in vitro and in vivo models. Recombinant receptor molecules can be used for specific inhibition of VEGF mediated signal transduction and for blocking tumor angiogenesis by limiting the amount of VEGF secreted from tumor cells or stroma cells. A naturally occurring soluble VEGFR-1 has been discovered in the supernatant from endothelial cells and at present appears to be the key regulator for the availability of VEGF secreted from different cells and tissues. The exact physiological role has not yet been demonstrated.</description><identifier>ISSN: 0969-6970</identifier><identifier>EISSN: 1573-7209</identifier><identifier>DOI: 10.1023/A:1009033017809</identifier><identifier>PMID: 14517442</identifier><identifier>CODEN: AGIOFT</identifier><language>eng</language><publisher>Germany: Springer Nature B.V</publisher><subject>Angiogenesis ; Blood vessels ; Endothelial cells ; Molecular modelling ; Receptors ; Signal transduction ; Stroma ; Tumor cells ; Tumors ; Vascular endothelial growth factor ; Vascular endothelial growth factor receptors</subject><ispartof>Angiogenesis (London), 1999-03, Vol.3 (1), p.33-39</ispartof><rights>Copyright (c) 1999 Kluwer Academic Publishers</rights><rights>Kluwer Academic Publishers 1999.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/14517442$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hornig, C</creatorcontrib><creatorcontrib>Weich, H A</creatorcontrib><title>Soluble VEGF receptors</title><title>Angiogenesis (London)</title><addtitle>Angiogenesis</addtitle><description>The three human VEGF receptors 1-3 mediate biological signals important for new blood vessel formation and lymphangiogenesis. Soluble VEGF receptors contain all the information necessary for high affinity ligand binding and have been used as experimental tools and regulators in several angiogenic in vitro and in vivo models. Recombinant receptor molecules can be used for specific inhibition of VEGF mediated signal transduction and for blocking tumor angiogenesis by limiting the amount of VEGF secreted from tumor cells or stroma cells. A naturally occurring soluble VEGFR-1 has been discovered in the supernatant from endothelial cells and at present appears to be the key regulator for the availability of VEGF secreted from different cells and tissues. The exact physiological role has not yet been demonstrated.</description><subject>Angiogenesis</subject><subject>Blood vessels</subject><subject>Endothelial cells</subject><subject>Molecular modelling</subject><subject>Receptors</subject><subject>Signal transduction</subject><subject>Stroma</subject><subject>Tumor cells</subject><subject>Tumors</subject><subject>Vascular endothelial growth factor</subject><subject>Vascular endothelial growth factor receptors</subject><issn>0969-6970</issn><issn>1573-7209</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1999</creationdate><recordtype>article</recordtype><sourceid>BENPR</sourceid><recordid>eNp10M1Lw0AQBfBFFBurV71JUfAWndmP2UxvpbRVKHjw4xqSzQZakiZmm4P_vRHrRfA0lx_vPUaIK4R7BKkeZlMEYFAK0CbARyJCY1VsJfCxiICJY2ILI3EWwhYGSok-FSPUBq3WMhKXL03V55WfvC9Wy0nnnW_3TRfOxUmZVcFfHO5YvC0Xr_PHeP28eprP1nGLwDImKiQp7YgyIiW_-yjxKvGsrDZgHFi2pSRiDWVRFjKhIncs88xJW4JTY3H3k9t2zUfvwz6tN8H5qsp2vulDSmyUMUYO8PYP3DZ9txu2pXJAyAioBnXzr0LUFtiaAV0fUJ_XvkjbblNn3Wf6-xT1BfJ5XhU</recordid><startdate>19990301</startdate><enddate>19990301</enddate><creator>Hornig, C</creator><creator>Weich, H A</creator><general>Springer Nature B.V</general><scope>NPM</scope><scope>3V.</scope><scope>7QO</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>19990301</creationdate><title>Soluble VEGF receptors</title><author>Hornig, C ; Weich, H A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p1092-66d2634c66a6632096968e38e9374505c0797f266940fdfd286dbc92bac27f0c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1999</creationdate><topic>Angiogenesis</topic><topic>Blood vessels</topic><topic>Endothelial cells</topic><topic>Molecular modelling</topic><topic>Receptors</topic><topic>Signal transduction</topic><topic>Stroma</topic><topic>Tumor cells</topic><topic>Tumors</topic><topic>Vascular endothelial growth factor</topic><topic>Vascular endothelial growth factor receptors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hornig, C</creatorcontrib><creatorcontrib>Weich, H A</creatorcontrib><collection>PubMed</collection><collection>ProQuest Central (Corporate)</collection><collection>Biotechnology Research Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Angiogenesis (London)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hornig, C</au><au>Weich, H A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Soluble VEGF receptors</atitle><jtitle>Angiogenesis (London)</jtitle><addtitle>Angiogenesis</addtitle><date>1999-03-01</date><risdate>1999</risdate><volume>3</volume><issue>1</issue><spage>33</spage><epage>39</epage><pages>33-39</pages><issn>0969-6970</issn><eissn>1573-7209</eissn><coden>AGIOFT</coden><abstract>The three human VEGF receptors 1-3 mediate biological signals important for new blood vessel formation and lymphangiogenesis. Soluble VEGF receptors contain all the information necessary for high affinity ligand binding and have been used as experimental tools and regulators in several angiogenic in vitro and in vivo models. Recombinant receptor molecules can be used for specific inhibition of VEGF mediated signal transduction and for blocking tumor angiogenesis by limiting the amount of VEGF secreted from tumor cells or stroma cells. A naturally occurring soluble VEGFR-1 has been discovered in the supernatant from endothelial cells and at present appears to be the key regulator for the availability of VEGF secreted from different cells and tissues. The exact physiological role has not yet been demonstrated.</abstract><cop>Germany</cop><pub>Springer Nature B.V</pub><pmid>14517442</pmid><doi>10.1023/A:1009033017809</doi><tpages>7</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0969-6970 |
| ispartof | Angiogenesis (London), 1999-03, Vol.3 (1), p.33-39 |
| issn | 0969-6970 1573-7209 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_69535552 |
| source | SpringerLink Journals |
| subjects | Angiogenesis Blood vessels Endothelial cells Molecular modelling Receptors Signal transduction Stroma Tumor cells Tumors Vascular endothelial growth factor Vascular endothelial growth factor receptors |
| title | Soluble VEGF receptors |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T07%3A28%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Soluble%20VEGF%20receptors&rft.jtitle=Angiogenesis%20(London)&rft.au=Hornig,%20C&rft.date=1999-03-01&rft.volume=3&rft.issue=1&rft.spage=33&rft.epage=39&rft.pages=33-39&rft.issn=0969-6970&rft.eissn=1573-7209&rft.coden=AGIOFT&rft_id=info:doi/10.1023/A:1009033017809&rft_dat=%3Cproquest_pubme%3E386043761%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=211470975&rft_id=info:pmid/14517442&rfr_iscdi=true |